Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **dentin-enamel junction (DEJ)** is the microscopic boundary where the enamel, the tooth’s hardest and most brittle tissue, meets dentin, its more flexible and resilient layer[1]. The DEJ exhibits a scalloped, graded transition zone of approximately 2–12 microns width, depending on the tooth region[2][3]. Compositionally, enamel is ~96% hydroxyapatite mineral, while dentin is about 70% mineral, 20% organic matrix (mainly collagen), and 10% fluid[1][2][4]. At the DEJ, mineral crystals from each tissue interconnect, and collagen fibers penetrate enamel, reinforcing the bond[2]. This interface is biomechanically specialized to prevent fracture propagation from enamel to dentin and allows stress transfer, supporting chewing function[1][2][3]. The DEJ also provides inspiration for bioengineered dental materials[7]. While critical for dental health, the DEJ is not a molecular drug target and is instead an essential tissue interface[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin-enamel junction (DEJ).